Brandon Kirsch, M.D. is a board-certified dermatologist. He is the Medical Director and Vice President of Clinical Development for Brickell Biotech, Inc. In his role, he has primary responsibility for overseeing development programs from preclinical to Phase 3 studies and post-approval commitments.
Brandon started his career as a lawyer and holds law degrees from the University of Western Ontario (LL.B.) and Georgetown (LL.M. Securities and Financial Regulation). He completed medical school at Brown University, an internship at the Mayo Clinic and dermatology residency at the University of North Carolina. In partnership with the Mayo Clinic, he filed to patent a novel topical composition for the treatment of melasma. Brandon has interests in therapeutic drug development and medical innovation.
Dermatology is recognized as a burgeoning area with exciting innovation for patients, doctors, and investors.
Pascale Communications was on the scene at the annual American Academy of Dermatology (AAD).
DENVER — R. Rox Anderson, MD, professor of dermatology at Harvard Medical School and director of the Wellman Center for …